메뉴 건너뛰기




Volumn 30, Issue 3, 2014, Pages

ERCC1 and BRCA1 mRNA expression predicts the clinical outcome of non-small cell lung cancer receiving platinum-based chemotherapy

Author keywords

BRCA1; ERCC1; Non small cell lung cancer; RRM1; Survival time

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; BETA ACTIN; BRCA1 PROTEIN; CARBOPLATIN; CISPLATIN; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; GEMCITABINE; MESSENGER RNA; NAVELBINE;

EID: 84897523954     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: 10.12669/pjms.303.4187     Document Type: Article
Times cited : (23)

References (21)
  • 1
    • 84897532554 scopus 로고    scopus 로고
    • International Agency for Research on Cancer. Lung cancer estimated incidence, Mortality and Prevalence Worldwide in 2012, Access on: 2014-2-1
    • International Agency for Research on Cancer. Lung cancer estimated incidence, Mortality and Prevalence Worldwide in 2012. 2012. http:// globocan.iarc.fr/factsheet.asp. Access on: 2014-2-1.
    • (2012)
  • 2
    • 70049112736 scopus 로고    scopus 로고
    • Revisiting stage IIIB and IV non-small cell lung cancer: Analysis of the surveillance, epidemiology, and end results data
    • DOI: 10.1378/chest.08-2968
    • William WN Jr, Lin HY, Lee JJ, Lippman SM. Revisiting stage IIIB and IV non-small cell lung cancer: Analysis of the surveillance, epidemiology, and end results data. Chest. 2009;136:701-709.DOI: 10.1378/chest.08-2968.
    • (2009) Chest , vol.136 , pp. 701-709
    • William Jr., W.N.1    Lin, H.Y.2    Lee, J.J.3    Lippman, S.M.4
  • 3
    • 84862280868 scopus 로고    scopus 로고
    • RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/ carboplatin-treated advanced non-small cell lung cancer
    • DOI: 10.1007/s00280-012- 1834-x
    • Zhang GB, Chen J, Wang LR, Li J, Li MW, Xu N, et al. RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/ carboplatin-treated advanced non-small cell lung cancer. Cancer Chemother Pharmacol. 2012;69(5):1277-1287.DOI: 10.1007/s00280-012- 1834-x.
    • (2012) Cancer Chemother Pharmacol , vol.69 , Issue.5 , pp. 1277-1287
    • Zhang, G.B.1    Chen, J.2    Wang, L.R.3    Li, J.4    Li, M.W.5    Xu, N.6
  • 4
    • 77955635233 scopus 로고    scopus 로고
    • Cancer statistics, 2010
    • DOI: 10.3322/caac.20073
    • Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277-300. DOI: 10.3322/caac.20073.
    • (2010) CA Cancer J Clin , vol.60 , Issue.5 , pp. 277-300
    • Jemal, A.1    Siegel, R.2    Xu, J.3    Ward, E.4
  • 5
    • 34548724426 scopus 로고    scopus 로고
    • Genetic variation in the DNA repair genes is predictive of outcome in lung cancer
    • DOI: 10.1093/hmg/ddm190
    • Matakidou A, el Galta R, Webb EL. Genetic variation in the DNA repair genes is predictive of outcome in lung cancer. Hum Mol Genet. 2007;16:2333-2340.DOI: 10.1093/hmg/ddm190.
    • (2007) Hum Mol Genet , vol.16 , pp. 2333-2340
    • Matakidou, A.1    Galta, E.R.2    Webb, E.L.3
  • 6
    • 79957745242 scopus 로고    scopus 로고
    • Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy
    • DOI: 10.1016/j.lungcan.2010.11.004
    • Liu L, Yuan P, Wu C, Zhang X, Wang F, Guo H, et al. Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer. 2011; 73(1):110-115.DOI: 10.1016/j.lungcan.2010.11.004.
    • (2011) Lung Cancer , vol.73 , Issue.1 , pp. 110-115
    • Liu, L.1    Yuan, P.2    Wu, C.3    Zhang, X.4    Wang, F.5    Guo, H.6
  • 7
    • 84874527959 scopus 로고    scopus 로고
    • BRCA1 and ERCC1 mRNA levels are associated with lymph node metastasis in Chinese patients with colorectal cancer
    • DOI: 10.1186/1471-2407-13-103
    • Yuanming L, Lineng Z, Baorong S, Junjie P, Sanjun C. BRCA1 and ERCC1 mRNA levels are associated with lymph node metastasis in Chinese patients with colorectal cancer. BMC Cancer. 2013;13:103.DOI: 10.1186/1471-2407-13-103.
    • (2013) BMC Cancer , vol.13 , pp. 103
    • Yuanming, L.1    Lineng, Z.2    Baorong, S.3    Junjie, P.4    Sanjun, C.5
  • 8
    • 84888780166 scopus 로고    scopus 로고
    • Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy
    • DOI: 10.1183/09059180.00007113
    • Bergot E, Levallet G, Campbell K, Dubois F, Lechapt E, Zalcman G. Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy. Eur Respir Rev. 2013;22(130):565-576.DOI: 10.1183/09059180.00007113.
    • (2013) Eur Respir Rev , vol.22 , Issue.130 , pp. 565-576
    • Bergot, E.1    Levallet, G.2    Campbell, K.3    Dubois, F.4    Lechapt, E.5    Zalcman, G.6
  • 9
    • 58149177773 scopus 로고    scopus 로고
    • Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in nonsmall- cell lung cancer patients
    • DOI: 10.1371/ journal.pone.0003695
    • Boukovinas I, Papadaki C, Mendez P, Taron M, Mavroudis D, Koutsopoulos A, et al. Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in nonsmall- cell lung cancer patients. PLoS One. 2008;3(11):e3695.DOI: 10.1371/ journal.pone.0003695.
    • (2008) PLoS One , vol.3 , Issue.11
    • Boukovinas, I.1    Papadaki, C.2    Mendez, P.3    Taron, M.4    Mavroudis, D.5    Koutsopoulos, A.6
  • 10
    • 77957814960 scopus 로고    scopus 로고
    • Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy
    • Fujita H, Ohuchida K, Mizumoto K, Itaba S, Ito T, Nakata K, et al. Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy. Neoplasia. 2010;12(10):807-817.
    • (2010) Neoplasia , vol.12 , Issue.10 , pp. 807-817
    • Fujita, H.1    Ohuchida, K.2    Mizumoto, K.3    Itaba, S.4    Ito, T.5    Nakata, K.6
  • 11
    • 84878738921 scopus 로고    scopus 로고
    • Prognostic potential of ERCC1 protein expression & clinicopathologic factors in stage III/N2 non-small cell lung cancer
    • DOI: 10.1186/1749-8090-8-149
    • Yan D, Wei P, An G, Chen W. Prognostic potential of ERCC1 protein expression & clinicopathologic factors in stage III/N2 non-small cell lung cancer. J Cardiothorac Surg. 2013;8:149.DOI: 10.1186/1749-8090-8-149.
    • (2013) J Cardiothorac Surg , vol.8 , pp. 149
    • Yan, D.1    Wei, P.2    An, G.3    Chen, W.4
  • 12
    • 84869496414 scopus 로고    scopus 로고
    • Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy
    • DOI: 10.1016/j.ejca.2012.06.011
    • Sodja E, Knez L, Kern I, Ovčariček T, Sadikov A, Cufer T. Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy. Eur J Cancer. 2012; 48(18):3378-3385.DOI: 10.1016/j.ejca.2012.06.011.
    • (2012) Eur J Cancer , vol.48 , Issue.18 , pp. 3378-3385
    • Sodja, E.1    Knez, L.2    Kern, I.3    Ovčariček, T.4    Sadikov, A.5    Cufer, T.6
  • 13
    • 84880370948 scopus 로고    scopus 로고
    • MRNA Expression and Clinical Significance of ERCC1, BRCA1, RRM1, TYMS and TUBB3 in Postoperative Patients with Non-Small Cell Lung Cancer
    • DOI: 10.7314/APJCP.2013.14.5.2987
    • Han Y, Wang XB, Xiao N, Liu ZD. mRNA Expression and Clinical Significance of ERCC1, BRCA1, RRM1, TYMS and TUBB3 in Postoperative Patients with Non-Small Cell Lung Cancer. Asian Pac J Cancer Prev. 2013;14(5):2987-2990.DOI: 10.7314/APJCP.2013.14.5.2987.
    • (2013) Asian Pac J Cancer Prev , vol.14 , Issue.5 , pp. 2987-2990
    • Han, Y.1    Wang, X.B.2    Xiao, N.3    Liu, Z.D.4
  • 14
    • 0344237226 scopus 로고    scopus 로고
    • Tumor response to chemotherapy: The validity and reproducibility of RECIST guidelines in NSCLC patients
    • DOI: 10.1111/j.1349- 7006.2003.tb01394.x
    • Watanabe H, Yamamoto S, Kunitoh H, Sekine I, Yamamoto N, Ohe Y, Tamura T, Kodama T, Sugimura K, Saijo N. Tumor response to chemotherapy: the validity and reproducibility of RECIST guidelines in NSCLC patients. Cancer Sci. 2003;94(11):1015-20.DOI: 10.1111/j.1349- 7006.2003.tb01394.x
    • (2003) Cancer Sci , vol.94 , Issue.11 , pp. 1015-1020
    • Watanabe, H.1    Yamamoto, S.2    Kunitoh, H.3    Sekine, I.4    Yamamoto, N.5    Ohe, Y.6    Tamura, T.7    Kodama, T.8    Sugimura, K.9    Saijo, N.10
  • 15
    • 0022534749 scopus 로고
    • Molecular characterization of the human excision repair gene ERCC-1: CDNA cloning and amino acid homology with the yeast DNA repair gene RAD10
    • DOI:10.1016/0092-8674(86)90014-0
    • van Duin M, de Wit J, Odijk H, Westerveld A, Yasui A, Koken MH, Hoeijmakers JH, Bootsma D. Molecular characterization of the human excision repair gene ERCC-1: cDNA cloning and amino acid homology with the yeast DNA repair gene RAD10. Cell. 1986;44(6):913-923.DOI:10.1016/0092-8674(86)90014-0.
    • (1986) Cell , vol.44 , Issue.6 , pp. 913-923
    • van Duin, M.1    de Wit, J.2    Odijk, H.3    Westerveld, A.4    Yasui, A.5    Koken, M.H.6    Hoeijmakers, J.H.7    Bootsma, D.8
  • 17
    • 84887156576 scopus 로고    scopus 로고
    • Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy
    • DOI: 10.1002/jso.23422
    • Huang MY, Tsai HL, Lin CH, Huang CW, Ma CJ, Huang CM, et al. Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy. J Surg Oncol. 2013;108(7):457-464.DOI: 10.1002/jso.23422.
    • (2013) J Surg Oncol , vol.108 , Issue.7 , pp. 457-464
    • Huang, M.Y.1    Tsai, H.L.2    Lin, C.H.3    Huang, C.W.4    Ma, C.J.5    Huang, C.M.6
  • 18
    • 84872737647 scopus 로고    scopus 로고
    • The effects of ERCC1 expression levels on the chemosensitivity of gastric cancer cells to platinum agents and survival in gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy
    • DOI: 10.3892/ol.2012.1096
    • Liu YP, Ling Y, Qi QF, Zhang YP, Zhang CS, Zhu CT, Wang MH, Pan YD. The effects of ERCC1 expression levels on the chemosensitivity of gastric cancer cells to platinum agents and survival in gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy. Oncol Lett. 2013;5(3):935-942.DOI: 10.3892/ol.2012.1096.
    • (2013) Oncol Lett , vol.5 , Issue.3 , pp. 935-942
    • Liu, Y.P.1    Ling, Y.2    Qi, Q.F.3    Zhang, Y.P.4    Zhang, C.S.5    Zhu, C.T.6    Wang, M.H.7    Pan, Y.D.8
  • 19
    • 84878386919 scopus 로고    scopus 로고
    • Clinicopathological significance of ERCC1 expression in breast cancer
    • DOI: 10.1016/j.prp.2013.02.009
    • Gerhard R, Carvalho A, Carneiro V, Bento RS, Uemura G, Gomes M, et al. Clinicopathological significance of ERCC1 expression in breast cancer. Pathol Res Pract. 2013;209(6):331-336.DOI: 10.1016/j.prp.2013.02.009.
    • (2013) Pathol Res Pract , vol.209 , Issue.6 , pp. 331-336
    • Gerhard, R.1    Carvalho, A.2    Carneiro, V.3    Bento, R.S.4    Uemura, G.5    Gomes, M.6
  • 20
    • 84874935746 scopus 로고    scopus 로고
    • Breast cancer susceptibility gene 1 (BRCA1) predict clinical outcome in platinum- and toxal-based chemotherapy in non-small-cell lung cancer (NSCLC) patients: A system review and metaanalysis
    • DOI: 10.1186/1756-9966-32-15
    • Yang Y, Xie Y, Xian L. Breast cancer susceptibility gene 1 (BRCA1) predict clinical outcome in platinum- and toxal-based chemotherapy in non-small-cell lung cancer (NSCLC) patients: a system review and metaanalysis. J Exp Clin Cancer Res. 2013;32:15.DOI: 10.1186/1756-9966-32-15.
    • (2013) J Exp Clin Cancer Res , vol.32 , pp. 15
    • Yang, Y.1    Xie, Y.2    Xian, L.3
  • 21
    • 75149189204 scopus 로고    scopus 로고
    • BRCA1 and its toolbox for the maintenance of genome integrity
    • DOI: 10.1038/nrm2831
    • Huen MS, Sy SM, Chen J. BRCA1 and its toolbox for the maintenance of genome integrity. Nat Rev Mol Cell Biol. 2010;11(2):138-148. DOI: 10.1038/nrm2831.
    • (2010) Nat Rev Mol Cell Biol , vol.11 , Issue.2 , pp. 138-148
    • Huen, M.S.1    Sy, S.M.2    Chen, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.